Policy
Changes
Dashboard
Pricing
Sign in
Sign up free
Home
/
Changes
/
Independence Blue Cross
/
08.00.04b, Crizanlizumab-tmca (Adakveo®)
Back to dashboard
All Plans
Administrative
Medium impact
08.00.04b, Crizanlizumab-tmca (Adakveo®)
Independence Blue Cross
·
Pharmacy
Effective date
Not stated
We identified it
Jun 25, 2026
Days to comply
—
Summary
Failed to analyze policy change
Action Required
Action needed
Manual review required
Related policy hubs
Independence Blue Cross policies